Nasal immunization with diphtheria toxoid conjugated-CD52 core peptide induced specific antibody production in genital tract of female mice

American Journal of Reproductive Immunology

Volumn 48, Issue 5, 2002, Pages 305-311

  Hasegawa, Akiko ^b   Fu, Yao ^b   Koyama, Koji ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b NONE

Author keywords

Contraceptive vaccine; Fertilization blocking; Liposome adjuvant; Mucosal immunity; Sperm coating antigen

Indexed keywords

CARRIER PROTEIN; CHOLERA TOXIN B SUBUNIT; CONTRACEPTIVE VACCINE; DIPTHERIA TOXOID CD52 CORE PEPTIDE CONJUGATE; FREUND ADJUVANT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN ANTIBODY; IMMUNOLOGICAL ADJUVANT; N [1 (2,3 DIOLEOYLOXY)PROPYL] N,N,N TRIMETHYLAMMONIUMMETHYLSULFATE CHOLESTEROL LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; CONTRACEPTION; CONTROLLED STUDY; DRUG SAFETY; DRUG SYNTHESIS; FEMALE; FEMALE GENITAL SYSTEM; IMMUNIZATION; IMMUNOGENICITY; INOCULATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; NOSE; PRIORITY JOURNAL; SERUM; SPERM; VAGINA SECRETION;

ANIMALS; ANTIGENS, CD; ANTIGENS, NEOPLASM; DIPHTHERIA TOXOID; FEMALE; GLYCOPROTEINS; IMMUNOGLOBULIN A; IMMUNOTOXINS; LIPOSOMES; PEPTIDES; RATS; VACCINATION; VAGINA;

EID: 0036828435     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0897.2002.01135.x     Document Type: Article

References (41)

1. Sanderson IR, Walker WA: Mucosal barrier: an overview. In Mucosal Immunology, PL Orga, J Mestedky, ME Lamm, W Strober, J Bierenstock, JR MacGhee, (eds). San Diego, Academic Press, 1999, pp. 5-17.
2. Mestecky J, McGhee JR, Arnold RR, Michalek SM, Prince SJ, Babb JL: Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest 1978; 61:731-737.
3. McDermott MR, Bienenstock J: Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J Immunol 1979; 122: 1892-1898.
4. Kiyono H, Bienenstock J, McGhee JR, Ernst PB: The mucosal immune system: features of inductive and effector sites to consider in mucosal immunization and vaccine development. Reg Immunol 1992; 4:54-62.
5. Underdown BJ, Schiff JM, Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu Rev Immunol 1986; 4:389-417.
6. Mestecky J, Russell MW, Jackson S, Brown TA: The human IgA system: a reassessment. Clin Immunol Immunopathol 1986; 40:105-114.
7. Mestecky J, McGhee JR: Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 1987; 40:153-245.
8. Wu HY, Russel MW: Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun 1993; 61:314-322.
9. Russell MW, Moldoveanu Z, White PL, Sibert GJ, Mestecky J, Michalek SM: Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit. Infect Immun 1996; 64:1272-1283.
10. Wu HY, Nikolova EB, Beagley KW, Russell MW: Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue. Immunology 1996; 88:493-500.
11. Wu HY, Abdu S, Stinson D, Russell MW: Generation of female genital tract antibody responses by local or central (common) mucosal immunization. Infect Immun 2000; 68:5539-5545.
12. Parr EL, Parr MB, Thapar M: A comparison of specific antibody responses in mouse vaginal fluid after immunization by several routes. J Reprod Immunol 1988; 14:165-176.
13. Mettler L, Czuppon AB, Tinneberg HR: Immunization with spermatozoal peptide antigens resulting in immunosuppression of fertility rates in female rats. Andrologia 1983; 15:670-675.
14. Allardyce R, Rademaker M: Female genital tract immunity and infertility after oral vaccination with sperm antigens in mice. Adv Exp Med Biol 1987; 216B:1807-1813.
15. Kameda K, Tsuji Y, Koyama K, Isojima S: Comparative studies of the antigens recognized by sperm-immobilizing monoclonal antibodies. Biol Reprod 1992; 46:349-357.
16. Schroter S, Derr P, Conradt HS, Nimtz M, Hale G, Kirchoff C: Male-specific modification of human CD52. J Biol Chem 1999; 274:29,862-29,873.
17. Diekman AB, Norton EJ, Westbrook VA, Klotz KL, Naaby-Hansen S, Herr JC: Anti-sperm antibodies from infertile patients and their cognate sperm antigens: a review. Identity between SAGA-1, the H6-3C4 antigen, and CD52. Am J Reprod Immunol 2000; 43:134-143.
18. Kirchhoff C, Schroter S: New insights into the origin, structure and role of CD52: a major component of the mammalian sperm glycocalyx. Cells Tissues Organs 2001;168:93-104.
19. Xia MQ, Tone M, Packman L, Hale G, Waldmann H: Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone. Eur J Immunol 1991; 21:1677-1684.
20. Tsuji Y, Clausen H, Nudelman E, Kaizu T, Hakomori S, Isojima S: Human sperm carbohydrate antigens defined by an antisperm human monoclonal antibody derived from an infertile woman bearing antisperm antibodies in her serum. J Exp Med 1988; 168:343-356.
21. McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H: The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992; 10:75-88.
22. Gallichan WS, Rosenthal KL: Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 1995; 13:1589-1595.
23. Staats HF, Nichols WG, Palker TJ: Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN (A). J Immunol 1996; 157:462-472.
24. Pal S, Peterson EM, de la Maza LM: Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge. Infect Immun 1996; 64:5341-5348.
25. Bergquist C, Johansson EL, Lagergard T, Holmgren J, Rudin A: Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun 1997; 65:2676-2684.
26. Wira CR, Sandoe CP: Sex steroid hormone regulation of IgA and IgG in rat uterine secretions. Nature 1977; 268:534-536.
27. McDermott MR, Clark DA, Bienstock J: Evidence for a common mucosal immunologic system. II. Influence of the estrous cycle on B immunoblast migration into genital and intestinal tissues. J Immunol 1980; 6: 2536-2539.
28. Wira CR, Sandoe CP: Hormonal regulation of immunoglobulins: influence of estradiol on immunoglobulins A and G in the rat uterus. Endocrinology 1980; 106:1020-1026.
29. Wira CR, Sandoe CP: Specific IgA and IgG antibodies in the secretions of the female reproductive tract: effects of immunization and estradiol on expression of this response in vivo. J Immunol 1987; 138:4159-4164.
30. Gallichan WS, Rosenthal KL: Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract. Virology 1996; 224:487-497.
31. Parr EL, Parr MB: Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2. Immunology 1999; 98:639-645.
32. Greer CE, Petracca R, Buonamassa DT, Di Tomasso A, Gervase B, Reeve RL, Ugozzoli M, Van Nest G, De Magistris MT, Benzi G: The comparison of the effect of LTR72 and MF59 adjuvants on mouse humoral response to intranasal immunisation with human papillomavirus type 6b (HPV-6b) virus-like particles. Vaccine 2000;19:1008-1012.
33. de Haan A, Tomee JF, Huchshorn JP, Wilschut J: Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice. Vaccine 1995; 13:1320-1324.
34. Morein B, Sundquist B, Hoglund S, Dalsgaard K, Osterhaus A: Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 1984; 308:457-460.
35. Eldridge JH, Staas JK, Meulbroek JA, McGhee JR, Tice TR, Gilley RM: Biodegradable microspheres as a vaccine delivery system. Mol Immunol 1991; 28:287-294.
36. Childers NK, Zhang SS, Michalek SM: Oral immunization of humans with dehydrated liposomes containing Streptococcus mutants glucosyltransferase induces salivary immunoglobulin A2 antibody responses. Oral Microbiol Immunol 1994; 9:146-153.
37. Gregoriadis G: Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol 1995; 13:527-537.
38. Michalek SM, O'Hagan DT Gould-Fogerite S, Rimmelzwaan GF, Osterhaus ADME: Antigen delivery systems, Nonliving Microparticles, liposomes, Cochleates and ISCOMS. In Mucosal Immunology, PL Orga, J Mestedsky, ME Lamm, W Strober, J Bierenstock, JR MaGhee (eds). San Diego, Academic Press, 1999; pp. 759-778.
39. Marinaro M, Boyaka PN, Jackson RJ, Finkelman FD, Kiyono H, Jirillo E, McGhee JR: Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin. J Immunol 1999; 162:114-121.
40. Walker C, Selby M, Erickson A, Cataldo D, Valensi JP, Van Nest GV: Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway. Proc Natl Acad Sci USA 1992; 89:7915-7918.
41. Chen W, Carbone FR, McCluskey J: Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen. J Immunol Meth 1993; 160:49-57.